Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Up – Still a Buy?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY)’s share price gapped up before the market opened on Tuesday. The stock had previously closed at $6.60, but opened at $6.95. Coloplast A/S shares last traded at $6.88, with a volume of 3,927 shares traded.

Coloplast A/S Stock Down 0.7%

The stock has a fifty day moving average of $6.72 and a 200 day moving average of $6.45. The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 0.94. The firm has a market capitalization of $15.51 billion, a P/E ratio of 36.21, a price-to-earnings-growth ratio of 2.47 and a beta of 0.21.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings data on Tuesday, August 18th. The company reported $0.10 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.10. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%. The firm had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.11 billion. On average, research analysts anticipate that Coloplast A/S Sponsored ADR will post 0.40 EPS for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology.

The company’s product portfolio includes ostomy bags and accessories, skin-protection products, intermittent catheters, bowel-management systems, and devices used in urological procedures. Recognized brands include SenSura and Brava in ostomy care, SpeediCath in continence care, and Peristeen for bowel management.

Coloplast traces its origins to the 1950s, when nurse Elise Sørensen developed an adhesive ostomy bag to help her sister manage an ileostomy.